DE69129115D1 - Neues verfahren zur behandlung von depression - Google Patents

Neues verfahren zur behandlung von depression

Info

Publication number
DE69129115D1
DE69129115D1 DE69129115T DE69129115T DE69129115D1 DE 69129115 D1 DE69129115 D1 DE 69129115D1 DE 69129115 T DE69129115 T DE 69129115T DE 69129115 T DE69129115 T DE 69129115T DE 69129115 D1 DE69129115 D1 DE 69129115D1
Authority
DE
Germany
Prior art keywords
new method
treating depression
depression
treating
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69129115T
Other languages
English (en)
Other versions
DE69129115T2 (de
Inventor
Jan David Wallace
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Application granted granted Critical
Publication of DE69129115D1 publication Critical patent/DE69129115D1/de
Publication of DE69129115T2 publication Critical patent/DE69129115T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69129115T 1990-10-12 1991-10-02 Neues verfahren zur behandlung von depression Expired - Fee Related DE69129115T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/596,270 US5025035A (en) 1990-10-12 1990-10-12 Method of treating depression
PCT/US1991/007330 WO1992006686A1 (en) 1990-10-12 1991-10-02 New method of treating depression

Publications (2)

Publication Number Publication Date
DE69129115D1 true DE69129115D1 (de) 1998-04-23
DE69129115T2 DE69129115T2 (de) 1998-07-16

Family

ID=24386662

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69129115T Expired - Fee Related DE69129115T2 (de) 1990-10-12 1991-10-02 Neues verfahren zur behandlung von depression

Country Status (11)

Country Link
US (1) US5025035A (de)
EP (1) EP0552240B1 (de)
JP (1) JP3192141B2 (de)
AT (1) ATE164065T1 (de)
CA (1) CA2092416A1 (de)
DE (1) DE69129115T2 (de)
DK (1) DK0552240T3 (de)
ES (1) ES2116298T3 (de)
GR (1) GR3026519T3 (de)
MX (1) MX9101526A (de)
WO (1) WO1992006686A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5025035A (en) * 1990-10-12 1991-06-18 Warner-Lambert Company Method of treating depression
US5510381A (en) * 1995-05-15 1996-04-23 Warner-Lambert Company Method of treatment of mania and bipolar disorder
EE9800309A (et) * 1996-03-14 1999-02-15 Warner-Lambert Company Uued asendatud tsüklilised aminohapped kui farmatseutilised toimeained
US6372792B1 (en) 1996-04-26 2002-04-16 Guy Chouinard Method for treating anxiety, anxiety disorders and insomnia
CN1094757C (zh) 1996-07-24 2002-11-27 沃尼尔·朗伯公司 用于治疗疼痛的异丁基γ－氨基丁酸及其衍生物
WO1999008667A2 (en) 1997-08-19 1999-02-25 Warner-Lambert Company Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotor stimulants
US6294690B1 (en) 1997-10-07 2001-09-25 Warner-Lambert Company Process for preparing a cyclic amino acid anticonvulsant compound
ES2260850T3 (es) * 1997-10-27 2006-11-01 Warner-Lambert Company Llc Aminoaciods ciclicos y sus derivados utiles como agentes farmaceuticos.
HU228772B1 (en) * 1998-05-15 2013-05-28 Warner Lambert Co Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same
EP1077692B1 (de) * 1998-05-15 2004-07-28 Warner-Lambert Company LLC Aminosäure-stabilisierte gabapentin und pregabalin zubereitungen und verfahren zu ihrer herstellung
US6992109B1 (en) * 1999-04-08 2006-01-31 Segal Catherine A Method for the treatment of incontinence
KR20010108466A (ko) * 1999-04-09 2001-12-07 로즈 암스트롱, 크리스틴 에이. 트러트웨인 우울증 치료용 ｇａｂａ 유사체와 삼환계 화합물의 복합제제
DK1169060T3 (da) * 1999-04-09 2006-01-16 Euro Celtique Sa Natriumkanalblokkerpræparater og anvendelse deraf
AP2002002501A0 (en) * 1999-10-07 2002-06-30 Warner Lambert Co Synergistic combinations of an NK1 receptor antagonist and a gaba structural analog.
DK1289364T3 (da) 2000-06-16 2004-04-13 Teva Pharma Stabil gapapentin som indeholder mere end 20 ppm chlorioner
ATE317280T1 (de) * 2001-09-03 2006-02-15 Newron Pharm Spa Pharmazeutische zusammensetzung mit gabapentin oder deren analog und einem alpha-aminoamid und analgetische verwendung dieser zusammensetzung
ITMI20012750A1 (it) 2001-12-21 2003-06-21 Procos Spa Processo per la produzione dell'acido 1-(amminometil)-cicloesil-acetico in forma pura
US20030119908A1 (en) * 2001-12-21 2003-06-26 Zambon Group S.P.A. Stable gabapentin compositions
US20050181071A1 (en) * 2004-02-18 2005-08-18 Binder Michael R. Method for the treatment of clinical depression
MX2007002713A (es) * 2004-09-10 2007-05-23 Newron Pharm Spa Uso de las (halobenciloxi) bencilamino-propanamidas para la fabricacion de medicamentos activos como moduladores selectivos de los canales de sodio y/o calcio.
EP2575798B1 (de) 2010-06-01 2017-08-09 Rubicon Research Private Limited Gastroretentive dosierungszubereitung von gaba analoga
EP2923694B1 (de) 2014-03-27 2018-11-14 Sanovel Ilac Sanayi ve Ticaret A.S. Orale flüssige pharmazeutische lösung von gabapentin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087544A (en) * 1974-12-21 1978-05-02 Warner-Lambert Company Treatment of cranial dysfunctions using novel cyclic amino acids
DE2460891C2 (de) * 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US5084479A (en) * 1990-01-02 1992-01-28 Warner-Lambert Company Novel methods for treating neurodegenerative diseases
US5025035A (en) * 1990-10-12 1991-06-18 Warner-Lambert Company Method of treating depression

Also Published As

Publication number Publication date
JPH06502148A (ja) 1994-03-10
EP0552240B1 (de) 1998-03-18
ES2116298T3 (es) 1998-07-16
CA2092416A1 (en) 1992-04-13
DE69129115T2 (de) 1998-07-16
ATE164065T1 (de) 1998-04-15
DK0552240T3 (da) 1998-11-23
US5025035A (en) 1991-06-18
JP3192141B2 (ja) 2001-07-23
EP0552240A1 (de) 1993-07-28
MX9101526A (es) 1992-06-05
WO1992006686A1 (en) 1992-04-30
GR3026519T3 (en) 1998-07-31
EP0552240A4 (en) 1993-09-01

Similar Documents

Publication Publication Date Title
ATE164065T1 (de) Neues verfahren zur behandlung von depression
DE69635493D1 (de) Verfahren zur herstellung von l-aminosäuren
DE69434672D1 (de) Verfahren zur behandlung von hühnereiern
DE69214610D1 (de) Verfahren zur Behandlung von Erdgas
DE69318433D1 (de) Verfahren zur Behandlung von Verbrennungsabgasen
DE69130431D1 (de) Verfahren zur Herstellung von azlacton-funktionellen Michael-Addukten
DE69019074D1 (de) Verfahren zur Fraktionierung von Plasmaproteinen.
DE69535721D1 (de) Verfahren zur Verbesserung von der Löslichkeit von pflanzlichen Proteinen
DE3888205D1 (de) Verfahren zur behandlung von lungenaffektionen und zubereitungen dafür.
DE69031447D1 (de) Verfahren zur Herstellung von MIS-Halbleiterbauelementen
DE69710422D1 (de) Verfahren zur Behandlung von Polyethern vor Hydrosilylation
DE69008820D1 (de) Verfahren zur Behandlung von Polymerisaten.
DE69102552D1 (de) Verfahren zur Behandlung von Fasermaterialien.
DE69129899D1 (de) Verfahren zur Herstellung von D-Alpha-Aminosäuren
DE69707033D1 (de) Verfahren zur Behandlung von Gasen die Organohalogenzusammensetzungen enthalten
DE69022269D1 (de) Verfahren zur thermischen Behandlung von Silizium.
DE59106539D1 (de) Verfahren zur Oberflächenbehandlung von Bauteilen.
DE59209268D1 (de) Verfahren zur thermochemisch-thermischen behandlung von einsatzstählen
ATE70067T1 (de) Peptidaminoalkoholderivate, welche ein tetrasubstituiertes kohlenstoffatom besitzen, hemmungsstoffe von renin und proteasesaeuren, verfahren zur herstellung und pharmazeutische zusammensetzungen.
DE69313556D1 (de) Verfahren zur Herstellung von zyklischen Depsipeptiden
DE69607559D1 (de) Verfahren zur Behandlung von Phenolteer
DE69500138D1 (de) Verfahren zur dauerhaften Verformung von Keratinmaterialien
DE69301936D1 (de) Verfahren zur Behandlung von Rauchgas
DE68926922D1 (de) Verfahren zur Herstellung von L-alpha-Aminosäuren
DE68922409D1 (de) Verfahren zur gasartigen reinigung von halbleiterbauelementen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee